MVD
protein-codingmevalonate diphosphate decarboxylase
Gene summary
The enzyme mevalonate pyrophosphate decarboxylase catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate in one of the early steps in cholesterol biosynthesis. It decarboxylates and dehydrates its substrate while hydrolyzing ATP. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013868
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0019497
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0013868
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013868
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0019212
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MVD variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002461.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 11 | 1 | 13 | ||
| missense | 2 | 95 | 8 | 1 | 106 | |
| nonsense | 0 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 2 | 6 | ||
| Total | 2 | 5 | 100 | 19 | 2 | 128 |
Highest pathogenic variant AF is 0.0033370098
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002452.1 | 10 | MANE Select | |
| Ensembl | ENSP00000301012.3 | 10 | MANE Select | |
| Ensembl | ENSP00000456465.1 | 2 | Standard | |
| Ensembl | ENSP00000458049.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mevalonate pathway
- Terpenoid backbone biosynthesis - Homo sapiens (human)
- Simvastatin Action Pathway
- Pravastatin Action Pathway
- Atorvastatin Action Pathway
Biological Process
- dolichyl diphosphate biosynthetic process
- cholesterol biosynthetic process
- positive regulation of cell population proliferation
- isoprenoid biosynthetic process
- isopentenyl diphosphate biosynthetic process, mevalonate pathway
Molecular Function
- diphosphomevalonate decarboxylase activity
- ATP binding
- Hsp70 protein binding
- protein homodimerization activity
Cellular Component
- peroxisome
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000301012
- Coding exons
- 10
- Length
- 11227
- Individuals with no LoFs
- 125657
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 51
- Defined
- 125708
- p
- 0.000203
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.363 | 286 | 269 | 1.06 | 0.0000188 | 2502 |
| Missense (PolyPhen) | 80 | 81.565 | 0.98081 | 778 | ||
| Synonymous | -1.20 | 136 | 119 | 1.14 | 0.00000862 | 838 |
| Loss of Function | -0.862 | 23 | 18.9 | 1.21 | 9.87e-7 | 202 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.00021 | 0.00020 | rare |
| East Asian | 0.00036 | 0.00033 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00010 | 0.000097 | rare |
| South Asian | 0.00087 | 0.00082 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Performs the first committed step in the biosynthesis of isoprenes.;
Recessive Scores
- pRec
- 0.198
Intolerance Scores
- RVIS EVS
- -1.06
- RVIS percentile EVS
- 7.52
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.999
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |